Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2003

Dec 19, 2003

29831_dirs_2003-12-19_fed9ff52-794b-4aed-a3bd-fc59100bf6e9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARQULE INC (ARQL)
CIK: 0001019695
Period of Report: 2003-12-17

Reporting Person: PFIZER INC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-12-17 Common stock J 645162 $2.67 Acquired 3273679 Indirect

Footnotes

F1: Shares acquired directly from ArQule as an additional equity investment.

F2: Joint Filer Information
Name: Pfizer Holdings Europe
Address: La Touche House - International Financial Services Centre - Dublin 1, Ireland
Designated Filer: Pfizer Inc.
Issuer and Ticker Symbol: ArQule, Inc. (ARQL)
Date of Event Requiring Statement: December 17, 2003.
Signature: Pfizer Holdings Europe

Signature of Reporting Person: /s/ Brian G. Byala, Director
Date: December 17, 2003